Aims & Scope

Biomedical Research and Therapy (ISSN 2198-4093) is the major forum for basic and translational research into therapies.

An international peer-reviewed journal, it publishes high quality open access research articles with a special emphasis on basic, translational and clinical research into molecular therapeutics and cellular therapies, including animal models and clinical trials.

The journal also provides reviews, viewpoints, commentaries and reports.

Biomedical Research and Therapy is an international, peer-reviewed, worldwide, open access journal.

It is dedicated to publishing high-quality manuscripts focusing on the biology and applications of biomedical research as well as therapy.

The journal explains the special emphasis on basic translational and clinical research into molecular and cellular therapeutics, including animal models and clinical trials.

Subject areas suitable for publication include, but are not limited to the following fields: - Gene editing- Gene correction- Immunotherapy- Cell/stem cell therapy- Targeting therapy- Gene therapy- Stem cell gene therapy- Gene transfer- Gene silencing, gene expression control- DNA vaccine- Biochemistry/biophysics- Cell biology, developmental biology- Genetics- Immunology- Molecular biology- Protein science- Structural biology- Translational medicine- Clinical trials.

View Aims & Scope

Metrics & Ranking

Impact Factor

Year Value
2025 0.5

Journal Rank

Year Value
2024 20726

Journal Citation Indicator

Year Value
2024 149

SJR (SCImago Journal Rank)

Year Value
2024 0.208

Quartile

Year Value
2024 Q4

Impact Factor Trend


Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.


Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.


Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.


Quick Facts

Current Factor
0.5
First Published: 2025

SJR (SCImago Journal Rank)

SJR
0.208
First Published: 2024

Quartile

Current Quartile
Q4
First Published: 2024

Similar Journals

Top Journals in Related Fields